Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 241

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 241
---
, included in general and administrative expense on the consolidated statements of loss and comprehensive loss.

The consideration paid to acquire Interactive consisted of net liabilities assumed of $50,000, recognized directly in shareholder's equity on completion of the RTO.

Upon closing of the transaction, the Company assumed liabilities of $2,071,580 for costs incurred by RBx that related to the BCA and RTO. The assumed liabilities have been expensed and included in the line item 'general and administrative' in the statement of operations and comprehensive loss for the year ended December 31, 2023.

<div align='center'>F-15

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.PURSUANT TO 17 C.F.R. SECTION 200.83</div>

4. Balance sheet components

Prepaid expenses include the following:

|                                 |   | Year ended December 31, 
                    2024 |     |   |    2023 |
|:--------------------------------|:--|------------------------:|:----|:--|--------:|
| Insurance                       | $ |                 583,561 |     | $ | 163,500 |
| Contract research organizations |   |                 455,810 |     |   |       - |
| Professional services           |   |                 144,643 |     |   |       - |
| Prepaid services                |   |                  29,970 |     |   |  10,219 |
|                                 | $ |               1,213,984 |     | $ | 173,719 |

Accrued expenses and other current liabilities include the following:

|                                   |   | Year ended December 31, 
                    2024 |     |   |    2023 |
|:----------------------------------|:--|------------------------:|:----|:--|--------:|
| Accrued legal fees                | $ |                 495,016 |     | $ | 359,011 |
| Accrued compensation and benefits |   |                 140,989 |     |   |  27,766 |
| Accrued other                     |   |                 126,830 |     |   |  18,040 |
|                                   | $ |                 762,835 |     | $ | 404,817 |

5. Leases

As of December 31, 2024, the Company had one operating lease for its corporate office that commenced in